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Introduction:  
C57BL/6 mice are the most widely used strain of laboratory mice. Using in vivo proton Magnetic Resonance Spectroscopy (1H MRS), we have 
repeatedly observed an abnormal neurochemical profile in the brains of both wild-type and genetically modified mice derived from the C57BL/6J 
strain, consisting of a several fold increase in cerebral glutamine (Gln) and two fold decrease in myo-inositol (Ins) (“High Gln” mice). This strikingly 
abnormal neurochemical “phenotype” resembles that observed in chronic liver disease or portosystemic shunting [1-4]. The aim of the present study 
was to determine if the C57BL/6J mice with the observed abnormal neurochemical profile showed evidence of portosystemic (PS) shunting, a 
congenital anomaly well described in other mammalian species [5-6].  
Methods: All our mice (C57BL/6J) were provided by official suppliers or different animal facilities. We are presenting only some of the “High Gln” 
mice identified in our laboratory (total of n=23 mice). In vivo serial 1H MRS spectra were measured during post natal day (P) 10, 20, 30, 60, 90 in the 
cortex of “Normal Gln” mice (n=11) and “High Gln” mice (n=11) to control for any developmental effect. In adult animals (4 and 12 months (n=12)), 
striatum, hippocampus and cortex were measured individually. All data were acquired on a 14.1T/26cm MRI system using the SPECIAL 
spectroscopy sequence (TE=2.8ms, TR=4s) [7]. First and second order shims were adjusted using FASTMAP. Concentrations of metabolites were 
calculated by LCModel using water as internal reference. Portal angiographies were performed on a digital subtraction angiography system equipped 
with a 40 × 48-cm flat panel detector (Allura Xper FD 20; Philips Medical System). Standard postero-anterior angiograms were obtained during 
continuous injection of iodinated contrast media (350 mg iodine/ml of iohexol, flow rate of 150 mL/h, n=5 for “Normal Gln” mice and n=5 for “High 
Gln” mice).  
Results and discussion: High Gln (3 fold increase, p<0.001) and 
low Ins concentrations (significant 30% decrease) were apparent in 
all brain regions in the “High Gln” mice (Fig 1A and B), and during 
brain development (data not shown). As many as 25% of 1H MRS 
scanned C57BL/6J mice in any given study showed the abnormal 
neurochemical profile. Findings were independent of transgene, 
type of investigation, chow or origin and were not associated with 
liver failure. 100% of the mice “High Gln” mice displayed 
portosystemic shunting by concomitant portal angiography while 
all mice with normal brain glutamine did not (Fig 2). The shunt was 
visible as a short segment that ran perpendicular to both the portal 
vein and inferior vena cava within the left side of the liver, 
consistent with a patent ductus venosus.  
To our knowledge, this is the first report showing that a high 
fraction of C57BL/6J mice present an abnormal neurochemical 
profile and that these changes are associated with the presence of 
congenital PS shunts. It is interesting to note that the same 
abnormal neurochemical profile was reported in a significant 
proportion of C57BL/6 mice [8], although the underlying cause was 
not identified.  
The commonly accepted pathophysiology of central nervous 
changes in liver disease and PS shunting is that portal blood 
bypasses the liver. Thus, ammonia enters the systemic circulation 
directly. In the CNS, ammonia is detoxified into Gln via the 
astrocyte-specific enzyme glutamine synthethase [4]. The end-result 
of CNS ammonia detoxification is elevated Gln concentration in 
astrocytes and efflux of other osmolytes [1-4]. We therefore 
conclude that the abnormal neurochemical profile detected in the C57BL/6J mice is 
most likely due to portosystemic shunting-induced CNS ammonia detoxification. 
The implications of the current findings are likely far-reaching: in humans, PS shunting 
is associated with many systemic changes, namely cardiac, renal, hepatic and 
pulmonary. Additionally, portosystemic shunting is known to cause alterations in gene 
expression in many organs including the brain [9-11]. We conclude that portosystemic 
shunting may be the most significant problem associated with C57BL/6 inbreeding both 
for its effect on the central nervous system and for its systemic repercussions.  
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Fig. 2: Aangiographies obtained in a “High Gln” mouse (A) and 
in a “Normal Gln” (B) C57BL/6J mouse. Normal filling of the 
portal tree is visible in B. In A, injection in the superior 
mesenteric vein leads to immediate filling of the inferior vena 
cava. Inferior vena cava (IVC), portal vein (PV), shunt (Sh).  
Fig. 1: A) In vivo spectra acquired at 14.1T in the cortex (VOI=0.8×4×1.2mm3) of 
“High Gln” and “Normal Gln” C57BL/6J mice.B) Metabolite concentrations in the 
striatum (str), hippocampus (hip) and cortex (ctx) of “High Gln” and “Normal Gln” 
C57BL/6 mice at 4 and 12 months of age. Statistically significant differences are 
marked *(p<0.05), **(p<0.01) and ***(p<0.001). 
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